Cart
sales@molnova.com
Probucol
CAS No. 23288-49-5
Probucol( DH 581 | Lorelco | NSC 86225 | NSC 652160 )
Catalog No. M13666 CAS No. 23288-49-5
Probucol is an anti-hyperlipidemic drug by lowering the level of cholesterol in the bloodstream by increasing the rate of LDL catabolism.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 33 | In Stock |
|
| 25MG | 29 | In Stock |
|
| 50MG | 39 | In Stock |
|
| 100MG | 54 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 75 | In Stock |
|
| 1G | 110 | In Stock |
|
Biological Information
-
Product NameProbucol
-
NoteResearch use only, not for human use.
-
Brief DescriptionProbucol is an anti-hyperlipidemic drug by lowering the level of cholesterol in the bloodstream by increasing the rate of LDL catabolism.
-
DescriptionProbucol is an anti-hyperlipidemic drug by lowering the level of cholesterol in the bloodstream by increasing the rate of LDL catabolism.
-
In Vitro——
-
In Vivo——
-
SynonymsDH 581 | Lorelco | NSC 86225 | NSC 652160
-
PathwayCell Cycle/DNA Damage
-
TargetABC
-
RecptorABCA1| CES1
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number23288-49-5
-
Formula Weight516.84
-
Molecular FormulaC31H48O2S2
-
Purity>98% (HPLC)
-
SolubilityEthanol: 103 mg/mL (199.28 mM); DMSO: 103 mg/mL (199.28 mM)
-
SMILESCC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C
-
Chemical Name2,6-ditert-butyl-4-[2-(3,5-ditert-butyl-4-hydroxyphenyl)sulfanylpropan-2-ylsulfanyl]phenol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jeon SM, et al. J Biochem Mol Toxicol. 2005, 19(5):336-46.
molnova catalog
related products
-
Glafenine Hydrochlor...
An anti-inflammatory agent.
-
Isosilybin A
Isosilybin A is a partial PPARγ agonist, it significantly induced ABCA1 protein expression, it inhibited both monophenolase (IC50=1.7-7.6μM) and diphenolase (IC50=12.1-44.9μM) of tyrosinase. Isosilybin A shows anti-angiogenic efficacy, it has anti-prostate cancer (PCA) activity that is mediated via cell cycle arrest and apoptosis induction.
-
DIDS sodium salt
DIDS sodium salt is a dual inhibitor of ABCA1 and VDAC1.
